Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

FDA clears Roche’s breakthrough drug Gazyva

First drug approved in US under new scheme

- PMLiVE

Merck stakes a claim to all-oral hepatitis C market

Positive data for interferon-free regimen

Roche - Basel

Roche signs €400m superbug deal

Buys rights to investigational antibiotic from Polyphor

- PMLiVE

Jeff Jonker joins Theravance

He has experience at Genentech

- PMLiVE

Novo enrols first patient in Tresiba cardiovascular trial

Milestone comes as diabetes-focused company reports solid growth

- PMLiVE

Electric dreams in medicine

Treating human disease with electrical impulses dates back decades, and now pharma is exploring the concept of ‘electroceuticals’ to complement drug-based therapy

- PMLiVE

FDA suspends sale of Ariad’s cancer drug

Iclusig linked to increased risk of blood clots

Bayer symbol

Bayer buoyant as new products drive pharma

Xarelto, Stivarga, Eylea and Xofigo all perform will in third quarter

- PMLiVE

FDA creates drug shortage plan

Manufacturers required to give early notice of potential shortfall of important medicines

- PMLiVE

To name and shame substandard healthcare?

Improving care by ‘naming and shaming’ hospitals or doctors remains a thorny issue

- PMLiVE

AZ names Dunoyer as CFO

He succeeds Simon Lowth as company restructure continues apace

Novartis building

Novartis weighs in on biosimilar naming debate

Files petition urging FDA to keep system where biosimilars share a name with the original drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links